发明名称 |
Oral formulations and lipophilic salts of methylnal trexone |
摘要 |
The present invention provides compositions comprising methylnaltrexone or a salt thereof, and compositions and formulations thereof, for oral administration. |
申请公布号 |
US8956651(B2) |
申请公布日期 |
2015.02.17 |
申请号 |
US201313966779 |
申请日期 |
2013.08.14 |
申请人 |
Wyeth, LLC |
发明人 |
Shah Syed M.;Diorio Christopher Richard;Ehrnsperger Eric C.;Meng Xu;Al Shareffi Kadum A.;Cohen Jonathan Marc |
分类号 |
A61K9/20;A61K31/485;C07D489/08;A61K9/28;A61K47/12;A61K47/20 |
主分类号 |
A61K9/20 |
代理机构 |
McCarter & English, LLP |
代理人 |
McCarter & English, LLP ;Sparks Jonathan M.;Gulati Maneesh |
主权项 |
1. A pharmaceutical composition for oral administration comprising a solid dosage of (i) methylnaltrexone, or a pharmaceutically acceptable salt thereof, and (ii) an amphiphilic pharmaceutically acceptable excipient, and wherein the composition comprises from about 7% to about 75% methylnaltrexone cation and an anion of the amphiphilic pharmaceutically acceptable excipient based upon the total weight of the composition and wherein the composition in solution has an apparent octanol/water partition coefficient for methylnaltrexone of at least 0.25 at a pH between 1 and 4. |
地址 |
Madison NJ US |